Effect of postdose fasting duration on hetrombopag olamine pharmacokinetics and pharmacodynamics in healthy volunteers

Yang, GP; Huang, RL; Yang, S; Zhang, XF; Yang, XY; Chen, HH; Huang, ZJ; Guo, CX; Pei, Q; Tai, YF; Shen, YC; Huang, J; Zou, C

Zou, C (corresponding author), Cent South Univ, Xiangya Hosp 3, Ctr Clin Pharmacol, Changsha 410013, Hunan, Peoples R China.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020; 86 (8): 1528

Abstract

Aims Hetrombopag olamine is a novel small-molecule, nonpeptide thrombopoietin receptor agonist developed for immune thrombocytopenia treatment. This s......

Full Text Link